274 related articles for article (PubMed ID: 33484569)
1. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study.
Cadham CJ; Cao P; Jayasekera J; Taylor KL; Levy DT; Jeon J; Elkin EB; Foley KL; Joseph A; Kong CY; Minnix JA; Rigotti NA; Toll BA; Zeliadt SB; Meza R; Mandelblatt J;
J Natl Cancer Inst; 2021 Aug; 113(8):1065-1073. PubMed ID: 33484569
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting.
Cao P; Smith L; Mandelblatt JS; Jeon J; Taylor KL; Zhao A; Levy DT; Williams RM; Meza R; Jayasekera J
JNCI Cancer Spectr; 2022 Jul; 6(4):. PubMed ID: 35818125
[TBL] [Abstract][Full Text] [Related]
3. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.
Villanti AC; Jiang Y; Abrams DB; Pyenson BS
PLoS One; 2013; 8(8):e71379. PubMed ID: 23940744
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of computed tomography screening for lung cancer in the United States.
McMahon PM; Kong CY; Bouzan C; Weinstein MC; Cipriano LE; Tramontano AC; Johnson BE; Weeks JC; Gazelle GS
J Thorac Oncol; 2011 Nov; 6(11):1841-8. PubMed ID: 21892105
[TBL] [Abstract][Full Text] [Related]
6. Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A model-based cost-effectiveness analysis.
Diaz M; Garcia M; Vidal C; Santiago A; Gnutti G; Gómez D; Trapero-Bertran M; Fu M;
Lung Cancer; 2021 Sep; 159():153-161. PubMed ID: 34352591
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
[TBL] [Abstract][Full Text] [Related]
8. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Smoking Cessation Interventions in Patients With Ischemic Stroke and Transient Ischemic Attack.
Wechsler PM; Liberman AL; Restifo D; Abramson EL; Navi BB; Kamel H; Parikh NS
Stroke; 2023 Apr; 54(4):992-1000. PubMed ID: 36866670
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of lung cancer screening combined with nurse-led smoking cessation intervention: A population-based microsimulation study.
Yuan J; Sun Y; Xu F; Li M; Fan M; Zhang C; Wang K; Li H; Bu X; Yan X; Wang J; Ma J; Zhang G; Chen M; Ren H
Int J Nurs Stud; 2022 Oct; 134():104319. PubMed ID: 35926265
[TBL] [Abstract][Full Text] [Related]
14. Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States.
Cao P; Jeon J; Levy DT; Jayasekera JC; Cadham CJ; Mandelblatt JS; Taylor KL; Meza R
J Thorac Oncol; 2020 Jul; 15(7):1160-1169. PubMed ID: 32160967
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
[TBL] [Abstract][Full Text] [Related]
17. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.
Taylor KL; Hagerman CJ; Luta G; Bellini PG; Stanton C; Abrams DB; Kramer JA; Anderson E; Regis S; McKee A; McKee B; Niaura R; Harper H; Ramsaier M
Lung Cancer; 2017 Jun; 108():242-246. PubMed ID: 28216065
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
Berndt N; Bolman C; Lechner L; Max W; Mudde A; de Vries H; Evers S
Eur J Health Econ; 2016 Apr; 17(3):269-85. PubMed ID: 25796578
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
Kowada A
BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
